# Investigate Effect of AMG 151 on 24-hour Ambulatory Blood Pressure & Glucose Levels in Type 2 Diabetes Mellitus Subjects

> **NCT01755442** · PHASE1 · TERMINATED · sponsor: **Amgen** · enrollment: 5 (actual)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **OTHER:** Placebo
- **DRUG:** AMG 151

## Key facts

- **NCT ID:** NCT01755442
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-11
- **Primary completion:** 2013-01
- **Final completion:** 2013-01
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Amgen determined no further need for this study.
- **Last updated:** 2013-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01755442

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01755442, "Investigate Effect of AMG 151 on 24-hour Ambulatory Blood Pressure & Glucose Levels in Type 2 Diabetes Mellitus Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01755442. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*